The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
TSH receptor autoantibody immunoassay in patients with Graves' disease: Improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis
Abstract
Background TSH receptor antibodies (TRAb) are the diagnostic hallmark of Graves' disease (GD) and immunoassays for their detection have been available for more than 30 years over three generations of laboratory methods. Despite a growing body of data produced by clinical and laboratory research which demonstrates its elevated sensitivity and specificity, TRAb testing is poorly used for diagnosing GD. The aim of our systematic review and meta-analysis is to verify the diagnostic performance of TRAb detected with 2nd and 3rd generation immunoassay methods.Methods We searched for English articles using MEDLINE with the search terms "TSH receptor antibody assay", "TSH Receptor antibody tests" and "Graves' disease". We analyzed studies reporting on TSH receptor antibody tests performed by quantitative immunoassays, on untreated patients with GD as the index disease (sensitivity) and on a control group of either healthy subjects or patients affected by other thyroid diseases (specificity). A total of 681 titles were initially identified with the search strategy described. 560 publications were excluded based on abstract and title. Full-text review was undertaken as the next step on 111 publications providing data on TRAb testing; 58 articles were subsequently excluded because they did not include untreated GD patients, or used either bioassays or 1st generation immunoassays. 32 were also excluded because they included data only on sensitivity or only on specificity of the assay, or were duplicates. Finally, 21 articles were selected for meta-analysis. Extraction of data from selected articles was performed by two authors independently, using predefined criteria: the number of patients with GD and the number of healthy or diseased controls; specification of the analytical method used to detect TRAb; sensitivity and specificity of the assay.Results The meta-analysis showed that the overall pooled sensitivity and specificity of the 2nd and 3rd generation TRAb assays are 97.1% and 97.4%, and 98.3% and 99.2%, respectively, with little difference between the types of immunoassay methods employed (human or porcine receptor, manual or automated procedure). The likelihood of a TRAb-positive individual to have GD is 1367- to 3420-fold greater (depending upon the type of assay) compared to a TRAb-negative person.Conclusions Data from the meta-analysis showed that TRAb measured with 2nd and 3rd generation immunoassay methods have very high sensitivity and specificity in the diagnosis of GD. The difference between 2nd and 3rd generation methods is small and is equally useful. In contrast with recommendations made by clinical endocrinologists who are not familiar with the state of the art in diagnostic technologies of autoimmunology laboratories, we propose a wide application of these tests in clinical practice to screen all hyperthyroid patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the setting of overt thyrotoxicosis, newer TRAb binding and bioassays have a sensitivity of 96-97% and a specificity of 99% for GD (56,57).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [57]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
DeGroot, L. J., Abalovich, M., Alexander, E. K., Amino, N., Barbour, L. A., Cobin, R. H., Eastman, C. J., Lazarus, J. H., Luton, D., Mandel, S. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2803 · Cited by 1,885
Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Abalovich, M., Amino, N., Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Stagnaro‐Green, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0141 · Cited by 934
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASE
SMITH, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91815-7 · Cited by 567
Costagliola, S., Morgenthaler, N. G., Hoermann, R., Badenhoop, K. W. J., Struck, J., Freitag, D., Poertl, S., Weglöhner, W., Hollidt, J. M., Quadbeck, B., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5415 · Cited by 341
Research works printed but not linked: 2
- Adams, 1956, Abnormal responses in the assay of thyrotropin, Proc Univ Otago Med Sch, 34, 11
- Gassner, 2007, Development of a new automated assay for thyrotropin receptor autoantibodies on the Elecsys system, Clin Chem, 53, A145
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“In the setting of overt thyrotoxicosis, newer TRAb binding and bioassays have a sensitivity of 96–97% and a specificity of 99% for GD (56,57).”
BackgroundSmith, T. J., & Hegedűs, L. D. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,338
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K. G., & Pearce, S. H. S. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 1,025
De Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases
Antonelli, A., Ferrari, S. M., Giuggioli, D., Ferrannini, E., Ferri, C., & Fallahi, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.010 · Cited by 595
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., Eckstein, A. K., Stagnaro‐Green, A., & Kahaly, G. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0184-y · Cited by 421
Diagnosis and management of Graves disease: a global overview
Bartalena, L. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.193 · Cited by 311
Diagnosis and classification of Graves' disease
Menconi, F., Marcocci, C., & Marinò, M. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.013 · Cited by 285
Clinical Utility of TSH Receptor Antibodies
Barbesino, G., & Tomer, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4309 · Cited by 237
Management of Graves Thyroidal and Extrathyroidal Disease: An Update
Kahaly, G. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa646 · Cited by 237
A 2013 European survey of clinical practice patterns in the management of Graves' disease
Bartalena, L., Burch, H. B., Burman, K. D., & Kahaly, G. J. (2014) · Clinical Endocrinology · doi:10.1111/cen.12688 · Cited by 197
Mikoś, H., Mikoś, M., Obara-Moszyńska, M., & Niedziela, M. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0021 · Cited by 145
Thyrotoxicosis: Diagnosis and Management
Sharma, A. R., & Stan, M. N. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.10.011 · Cited by 116
TSH Receptor Antibodies: Relevance & Utility
Kahaly, G. J., Diana, T., & Olivo, P. D. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0363 · Cited by 94
Testing, Monitoring, and Treatment of Thyroid Dysfunction in Pregnancy
Lee, S. Y., & Pearce, E. N. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa945 · Cited by 99
Diagnosis and management of thyrotoxicosis
Vaidya, B., & Pearce, S. H. S. (2014) · BMJ · doi:10.1136/bmj.g5128 · Cited by 91
Graves’ hyperthyroidism in pregnancy: a clinical review
Nguyen, C. T., Sasso, E. B., Barton, L., & Mestman, J. H. (2018) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-018-0054-7 · Cited by 94
Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance
Bucci, I., Giuliani, C., & Napolitano, G. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00137 · Cited by 81
Scappaticcio, L., Trimboli, P., Keller, F., Imperiali, M., Piccardo, A., & Giovanella, L. (2019) · Clinical Endocrinology · doi:10.1111/cen.14130 · Cited by 76
Pathophysiology of thyroid-associated orbitopathy
Lee, A. C. H., & Kahaly, G. J. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101620 · Cited by 75
Thyrotropin Receptor Antibodies—An Overview
Kotwal, A., & Stan, M. N. (2018) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000001052 · Cited by 73
Graves’ Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature
Brancatella, A., Viola, N., Brogioni, S., Montanelli, L., Sardella, C., Vitti, P., Marcocci, C., Lupi, I., & Latrofa, F. (2019) · European Thyroid Journal · doi:10.1159/000501824 · Cited by 69
Tozzoli, R., D’Aurizio, F., Villalta, D., & Giovanella, L. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0197 · Cited by 68
Self-citationZhou, L., Liu, Y., Wang, F., Jia, Z., Zhou, J., Jiang, T., Petti, L., Chen, Y., Xiong, Q., & Wang, X. (2018) · Talanta · doi:10.1016/j.talanta.2018.05.070 · Cited by 63
Diana, T., & Kahaly, G. J. (2018) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000001053 · Cited by 62
Iodoprophylaxis and thyroid autoimmunity: an update
Teti, C., Panciroli, M., Nazzari, E., Pesce, G., Mariotti, S., Olivieri, A., & Bagnasco, M. (2021) · Immunologic Research · doi:10.1007/s12026-021-09192-6 · Cited by 61
Self-citationInsights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors
Lui, D. T. W., Lee, C., Chow, W. S., Lee, A. C. H., Tam, A. R., Fong, C. H. Y., Law, C. Y., Leung, E. K. H., To, K. K., Tan, K. C. B., et al. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.983 · Cited by 61
Measuring TSH receptor antibody to influence treatment choices in Graves’ disease
Asha, H. S., & Abraham, P. (2017) · Clinical Endocrinology · doi:10.1111/cen.13327 · Cited by 61
Lata, K., Dutta, P., Sridhar, S., Rohilla, M., Srinivasan, A., Prashad, G. R. V., Shah, V. N., & Bhansali, A. (2013) · Endocrine Connections · doi:10.1530/ec-13-0012 · Cited by 60
Relapse following antithyroid drug therapy for Graves’ hyperthyroidism
Laurberg, P., Krejbjerg, A., & Andersen, S. L. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000088 · Cited by 60
Holthoff, H., Goebel, S., Li, Z., Faßbender, J., Reimann, A., Zeibig, S., Lohse, M. J., Münch, G., & Ungerer, M. (2015) · Endocrinology · doi:10.1210/en.2014-1813 · Cited by 56
Wang, Z., Yang, H., Wang, M., Petti, L., Jiang, T., Jia, Z., Xie, S., & Zhou, J. (2018) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2018.02.069 · Cited by 57
Ide, A., Amino, N., Kang, S., Yoshioka, W., Kudo, T., Nishihara, E., Ito, M., Nakamura, H., & Miyauchi, A. (2014) · Thyroid® · doi:10.1089/thy.2013.0585 · Cited by 56
Outcome Prediction of Treatment of Graves’ Hyperthyroidism with Antithyroid Drugs
Piantanida, E., Lai, A., Sassi, L., Gallo, D., Spreafico, E., Tanda, M. L., & Bartalena, L. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1555759 · Cited by 53
Ma, Y., Liu, H., Chen, Y., Du, Y., Gu, C., Zhao, Z., Si, H., Wei, G., Jiang, T., & Zhou, J. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c00652 · Cited by 48
Kwon, H., Kim, W. G., Jang, E. K., Kim, M., Park, S., Jeon, M. J., Kim, T. Y., Ryu, J., Shong, Y. K., & Kim, W. B. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.300 · Cited by 40
Peak Systolic Velocity of Superior Thyroid Artery for the Differential Diagnosis of Thyrotoxicosis
Zhao, X., Chen, L., Li, L., Wang, Y., Wang, Y., Zhou, L., Zeng, F., Li, Y., Hu, R., & Liu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050051 · Cited by 39
Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test
Bell, L., Hunter, L., Kyriacou, A., Mukherjee, A., & Syed, A. A. (2018) · Endocrine Connections · doi:10.1530/ec-18-0082 · Cited by 39
Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
Inaba, H., DeGroot, L. J., & Akamizu, T. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00120 · Cited by 38
Autilio, C., Morelli, R., Locantore, P., Pontecorvi, A., Zuppi, C., & Carrozza, C. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217700655 · Cited by 37
Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance
Ungerer, M., Faßbender, J., Li, Z., Münch, G., & Holthoff, H. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8562-7 · Cited by 33
Ji, D. Y., Park, S. H., Park, S. J., Kim, K. H., Ku, C. R., Shin, D. Y., Yoon, J. S., Lee, D. Y., & Lee, E. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27600-0 · Cited by 33
Diagnostic procedure in suspected Graves’ disease
Goichot, B., Leenhardt, L., Massart, C., Raverot, V., Tramalloni, J., & Iraqi, H. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.08.002 · Cited by 32
Kim, Y. A., Cho, S. W., Choi, H. S., Moon, S., Moon, J. H., Kim, K. W., Park, D. J., Yi, K. H., Park, Y. J., & Cho, B. Y. (2016) · Thyroid · doi:10.1089/thy.2016.0056 · Cited by 32
Davies, T. F., Laurberg, P., & Bahn, R. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00012-5 · Cited by 32
Holthoff, H., Li, Z., Faßbender, J., Reimann, A., Adler, K., Münch, G., & Ungerer, M. (2017) · Endocrinology · doi:10.1210/en.2016-1845 · Cited by 31
Struja, T., Jutzi, R., Imahorn, N., Kaeslin, M., Boesiger, F., Kutz, A., Mundwiler, E., Huber, A., KRAENZLIN, M. E., Müeller, B., et al. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0363-6 · Cited by 31
Villalta, D., D’Aurizio, F., Re, M. D., Ricci, D., Latrofa, F., & Tozzoli, R. (2018) · Autoimmunity Highlights · doi:10.1007/s13317-018-0102-4 · Cited by 27
Self-citationAlemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management
Mahzari, M., Arnaout, A., & Freedman, M. S. (2015) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2015.48 · Cited by 26
Kim, J., Choi, M. S., Park, J. T., Park, H., Jang, H. W., Choe, J., Kim, J., Kim, J. S., Cho, Y. S., Choi, J. Y., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0756 · Cited by 26
Negro, R., Attanasio, R., Grimaldi, F., Guglielmi, R., & Papini, E. (2016) · European Thyroid Journal · doi:10.1159/000444482 · Cited by 25
Chazova, I. E., Михайловна, Ч. Н., Blinova, N. V., Belaya, Z. E., Danilov, N. M., Elfimova, E. M., Litvin, A. Y., Rozhinskaya, L. Y., Sviridenko, N. Y., Швецов, М. Ю., et al. (2023) · Eurasian heart journal · doi:10.38109/2225-1685-2023-1-6-65 · Cited by 30
Management of Thyrotoxicosis: Preconception, Pregnancy, and the Postpartum Period
Pearce, E. N. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0356 · Cited by 26
Thyroid disease: Using diagnostic tools effectively
Croker, E. E., McGrath, S. A., & Rowe, C. W. (2021) · Australian Journal of General Practice · doi:10.31128/ajgp-10-20-5693 · Cited by 23
Deligiorgi, M. V., Sagredou, S., Vakkas, L., & Trafalis, D. T. (2021) · Cancers · doi:10.3390/cancers13215277 · Cited by 22
Graves’ hyperthyroidism in pregnancy
Nguyen, C. T., & Mestman, J. H. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000492 · Cited by 22
Prasek, K., Płazińska, M. T., & Królicki, L. (2015) · Nuclear Medicine Review · doi:10.5603/nmr.2015.0026 · Cited by 19
Giuliani, C., Saji, M., Bucci, I., & Napolitano, G. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00103 · Cited by 19
Kim, J. J., Jeong, S.-H., Kim, B., Kim, D., & Jeong, S. H. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1658216 · Cited by 18
Autoimmune Thyroid Disorders in Autoimmune Addison Disease
Stokland, A. M., Ueland, G. Å., Lima, K., Grønning, K., Finnes, T. E., Svendsen, M., Tomkowicz, A., Holte, S. E., Sollid, S. T., Dębowska, A., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac089 · Cited by 20
Sugamata, Y., Uchiyama, R., Honda, T., Tanaka, T., Matsunaga, T., & Yoshino, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714426 · Cited by 18
Receptor autoimmunity: diagnostic and therapeutic implications
Tozzoli, R. (2020) · Autoimmunity Highlights · doi:10.1186/s13317-019-0125-5 · Cited by 17
Self-citationOrtega, J. M. L., Martínez, P. S., Acevedo-León, D., & Capell, N. E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270890 · Cited by 16
Thyroid stimulating receptor autoantibodies
Gao, Y., Qiu, L., Yu, S., & Cheng, X. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119700 · Cited by 15
Antithyroid drug therapy in pregnancy: a review of guideline recommendations
Khan, I. N., Okosieme, O. E., & Lazarus, J. H. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1338944 · Cited by 16
Sarangi, P. K., Parida, S., Mangaraj, S., Mohanty, B. K., Mohanty, J., & Swain, B. M. (2021) · Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · doi:10.1055/s-0041-1734360 · Cited by 15
Current controversies in the management of Graves’ hyperthyroidism
Francis, N., Francis, T., Lazarus, J. H., & Okosieme, O. E. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1754192 · Cited by 16
Rethinking screening for thyroid autoimmunity in vitiligo
Liu, M., Murphy, E. J., & Amerson, E. H. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.04.029 · Cited by 15
Baek, H.-S., Lee, J., Jeong, C., Lee, J., Ha, J., Jo, K., Kim, M., Cho, J., Kang, M. I., & Lim, D. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac023 · Cited by 14
Liu, T., Zhang, X., Li, L., Zhou, L., Chen, J., Li, M., Gao, Y., Zhou, X., Han, X., & Ji, L. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01114-3 · Cited by 14
The role of laboratory medicine in the diagnosis of the hyperthyroidism
D’Aurizio, F. (2021) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.21.03344-6 · Cited by 13
Liu, K., Fu, Y., Li, T., Liu, S., Chen, D., Zhao, C., Shi, Y., Cai, Y., Yang, T., & zheng, X. (2021) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.07.014 · Cited by 12
Sensitivity of three thyrotropin receptor antibody assays in thyroid-associated orbitopathy
Matutinović, M. S., Diana, T., Nedeljković-Beleslin, B., Ćirić, J., Žarković, M., Perović-Blagojević, I., Kahaly, G., & Ignjatović, S. (2021) · Journal of Medical Biochemistry · doi:10.5937/jomb0-34718 · Cited by 12
Thyrotropin receptor antibody: A novel risk indicator for pregnancy loss
Li, Y., Xu, T., Mo, Q., Fu, W., & Yao, C. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.11.017 · Cited by 12
Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis
Perdomo, C. M., García‐Goñi, M., Sancho, L., Paricio, J. J., Lozano, M. D., de la Higuera, M., Currás, M., Arbizu, J., & Galofré, J. C. (2020) · Clinical Endocrinology · doi:10.1111/cen.14308 · Cited by 11
Tong, M., Ding, J., Huang, B., Chen, J., Wei, X., Li, Z., Shu, J., Hu, Z., Jiang, X., & Sheng, H. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.06.017 · Cited by 11
Brancatella, A., Torregrossa, L., Viola, N., Sgrò, D., Casula, M., Basolo, F., Materazzi, G., Marinò, M., Marcocci, C., Santini, F., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02044-0 · Cited by 11
Harmonization in autoimmune thyroid disease diagnostics
Tozzoli, R., & Bizzaro, N. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0037 · Cited by 11
Self-citationCase 38-2015: A 21-Year-Old Man with Fatigue and Weight Loss
Pallais, J. C., McInnis, M., Saylor, P. J., & Wu, R. I. (2015) · New England Journal of Medicine · doi:10.1056/nejmcpc1506821 · Cited by 9
Thyroid Ultrasonography: Much Ado About Nothing? A Provocative Analysis
Ovčariček, P. P., & Giovanella, L. (2025) · Cancers · doi:10.3390/cancers17111764 · Cited by 12
Irisin and Myostatin Levels in Patients with Graves' Disease
Yalçın, M. M., Aktürk, M., Tohma, Y., Cerit, E. T., Altınova, A. E., Arslan, E., Yetkin, İ., & Törüner, F. B. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.11.002 · Cited by 10
Higgins, V., Patel, K., Kulasingam, V., Beriault, D. R., Rutledge, A. C., & Selvaratnam, R. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.08.007 · Cited by 10
de Morais, N. S., Angell, T. E., Ahmadi, S., Alexander, E. K., Teixeira, P. D. F. D. S., & Marqusee, E. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.01.007 · Cited by 10
Schwiebert, C., Kühnen, P., Becker, N., Welsink, T., Keller, T., Minich, W. B., Wiegand, S., & Schomburg, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020463 · Cited by 10
Thyrotoxicosis after COVID-19 Infection with a Delay in Graves’ Disease Antibody Positivity
Boyle, D., & Mullally, J. A. (2023) · Case Reports in Endocrinology · doi:10.1155/2023/8402725 · Cited by 9
Spencer‐Bonilla, G., Ospina, N. S., Rodríguez‐Gutiérrez, R., Brito, J. P., Iñiguez‐Ariza, N. M., Tamhane, S. U., Erwin, P. J., Murad, M. H., & Montori, V. M. (2017) · Endocrine · doi:10.1007/s12020-017-1298-1 · Cited by 9
Hötte, G. J., de Bie, M., de Keizer, R. O. B., Kolijn, P. M., Drexhage, R. C., Veenbergen, S., Versnel, M. A., van Hagen, P. M., Paridaens, D. A., & Dik, W. A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1469179 · Cited by 8
Stan, M. N., Algeciras‐Schimnich, A., Murthy, V., Thapa, P. B., & Araki, N. (2021) · Thyroid · doi:10.1089/thy.2021.0299 · Cited by 8
Quinn, M., Bashari, W. A., Smith, D., Gurnell, M., & Agha, A. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00611-7 · Cited by 8
Hu, Y., Ni, J., Cen, Y., Zhang, B., Wu, W., Cheng, W., Huang, M., & Guan, M. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23950 · Cited by 8
Baek, H.-S., Kim, J., Jeong, C., Lee, J., Ha, J., Jo, K., Kim, M., Sohn, T. S., Lee, I. S., Lee, J. M., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae254 · Cited by 7
Bizzaro, N., Bagnasco, M., Tozzoli, R., Brusca, I., Cinquanta, L., Tampoia, M., Deleonardi, G., Antico, A., Pesce, G., Alessio, M. G., et al. (2018) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-018-0181-2 · Cited by 7
Self-citationFadeev, V. V. (2020) · Clinical and experimental thyroidology · doi:10.14341/ket12474 · Cited by 9
Wu, Z., Zhu, Y. M., Zhang, M., Wang, C., Zhou, L., Liu, W., Yang, W., Li, M., Zhang, S., Ren, Q., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.620407 · Cited by 7
Positive Thyrotropin Receptor Antibodies in Patients with Transient Thyrotoxicosis
Angell, T. E., Benschoten, O. V., Cohen, D. A., Haas, A. V., Alexander, E. K., & Marqusee, E. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0059 · Cited by 7
Klit, F. Ø., Dal, J., Andersen, S. L., Nikontovic, A., Vestergaard, P., & Karmisholt, J. (2024) · Clinical Epidemiology · doi:10.2147/clep.s484335 · Cited by 6
Gan, D., Gao, T., Ma, L., Lü, H., Dai, H., Liu, Q.-Y., Lai, Y., Xin-hui, L., Peng, Z.-D., Chen, R.-Y., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119106 · Cited by 6
Kalra, S., Selim, S., Shrestha, D., Somasundaram, N. P., Raza, S. A., Baruah, M., Bhattacharya, S., GADVE, S. S., Bantwal, G., & Sahay, R. K. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01809-9 · Cited by 7
Applications of Cell-Based Bioassays Measuring The Induced Expression of Endogenous Genes
Moore, M. L., Ferguson, J., & Burns, C. J. (2014) · Bioanalysis · doi:10.4155/bio.14.98 · Cited by 6
Thyrotropin Receptor Antibodies
Tozzoli, R., Bagnasco, M., & Villalta, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-56378-1.00045-9 · Cited by 6
Self-citation
Metadata
- Authors
- Tozzoli, R., Bagnasco, M., Giavarina, D., & Bizzaro, N.
- Affiliations
- Azienda Ospedaliera Santa Maria Degli Angeli (IT)
- University of Genoa (IT)
- Ospedale San Bortolo (IT)
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 12
- Issue
- 2
- Pages
- 107-113
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W1967526742
- Cited by
- 195
- References
- 56
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 16 · 2023: 12 · 2022: 22 · 2021: 27 · 2020: 20 · 2019: 11 · 2018: 19 · 2017: 7 · 2016: 19 · 2015: 7 · 2014: 8 · 2013: 9 · 2012: 1
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Autoimmunity Reviews (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- TSH receptor antibodies, Graves' disease, diagnostic accuracy, sensitivity and specificity, automated immunoassay, diagnostic performance, thyroid autoimmunity
- MeSH terms
- Autoantibodies, Graves Disease, Humans, Immunologic Tests, Receptors, Thyrotropin, Sensitivity and Specificity, Reproducibility of Results, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review